The Global Rabies Vaccine Market Size is projected to expand from USD 1.12 Billion in 2025 to USD 1.54 Billion by 2033, registering a CAGR of 4.3%

The Global Human Rabies Vaccines Market was valued at USD 963.53 Million in 2022 and is expected to reach USD 1,391.36 Million by 2030, growing at a CAGR of 4.7% (2023-2030).